81_FR_9907 81 FR 9869 - Submission for OMB Review; 30-Day Comment Request: The National Physician Survey of Precision Medicine in Cancer Treatment (NCI) [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. For Further Information Contact: To obtain a copy of the data collection plans and instruments, or request more information on the proposed project, contact: Janet S. de Moor, Ph.D., MPH, Project Officer, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, 3E438, MSC 9764, Rockville, MD, 20850 or call non-toll-free number 240-276-6806 or Email your request, including your address to: [email protected] Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: The National Physician Survey of Precision Medicine in Cancer Treatment 0925-NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: The purpose of this study is to investigate the current practice of precision medicine in cancer treatment among medical oncologists in the U.S. This is a nationally representative survey designed to assess oncologists' current and potential use of genomic testing, to inform the development of interventions to facilitate optimal use of genomic testing and to improve patient-physician discussions of the risks, possible benefits, and uncertainties surrounding the use of these tests. Current knowledge of this topic is limited as there are no nationally-representative studies on this topic to date. There are only two non-federal studies two that have examined physicians' knowledge and attitudes regarding somatic genetic and genomic testing. The survey will be administered by mail and web to medical oncology physicians across the U.S. Non- respondents will be invited to complete a follow-back survey to share their reasons for not participating. The study findings will inform NCI of relevant issues and concerns relating to the application of precision medicine to current and future cancer treatment patterns and practice. This information will also inform the development of new funding initiatives to optimize the use of precision medicine in cancer treatment. Additionally, information collected as part of this survey will be used to develop physician educational materials to address barriers to precision medicine in cancer care delivery. OMB approval is requested for 2 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 350."> [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. For Further Information Contact: To obtain a copy of the data collection plans and instruments, or request more information on the proposed project, contact: Janet S. de Moor, Ph.D., MPH, Project Officer, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, 3E438, MSC 9764, Rockville, MD, 20850 or call non-toll-free number 240-276-6806 or Email your request, including your address to: [email protected] Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: The National Physician Survey of Precision Medicine in Cancer Treatment 0925-NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: The purpose of this study is to investigate the current practice of precision medicine in cancer treatment among medical oncologists in the U.S. This is a nationally representative survey designed to assess oncologists' current and potential use of genomic testing, to inform the development of interventions to facilitate optimal use of genomic testing and to improve patient-physician discussions of the risks, possible benefits, and uncertainties surrounding the use of these tests. Current knowledge of this topic is limited as there are no nationally-representative studies on this topic to date. There are only two non-federal studies two that have examined physicians' knowledge and attitudes regarding somatic genetic and genomic testing. The survey will be administered by mail and web to medical oncology physicians across the U.S. Non- respondents will be invited to complete a follow-back survey to share their reasons for not participating. The study findings will inform NCI of relevant issues and concerns relating to the application of precision medicine to current and future cancer treatment patterns and practice. This information will also inform the development of new funding initiatives to optimize the use of precision medicine in cancer treatment. Additionally, information collected as part of this survey will be used to develop physician educational materials to address barriers to precision medicine in cancer care delivery. OMB approval is requested for 2 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 350." /> [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. For Further Information Contact: To obtain a copy of the data collection plans and instruments, or request more information on the proposed project, contact: Janet S. de Moor, Ph.D., MPH, Project Officer, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, 3E438, MSC 9764, Rockville, MD, 20850 or call non-toll-free number 240-276-6806 or Email your request, including your address to: [email protected] Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: The National Physician Survey of Precision Medicine in Cancer Treatment 0925-NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: The purpose of this study is to investigate the current practice of precision medicine in cancer treatment among medical oncologists in the U.S. This is a nationally representative survey designed to assess oncologists' current and potential use of genomic testing, to inform the development of interventions to facilitate optimal use of genomic testing and to improve patient-physician discussions of the risks, possible benefits, and uncertainties surrounding the use of these tests. Current knowledge of this topic is limited as there are no nationally-representative studies on this topic to date. There are only two non-federal studies two that have examined physicians' knowledge and attitudes regarding somatic genetic and genomic testing. The survey will be administered by mail and web to medical oncology physicians across the U.S. Non- respondents will be invited to complete a follow-back survey to share their reasons for not participating. The study findings will inform NCI of relevant issues and concerns relating to the application of precision medicine to current and future cancer treatment patterns and practice. This information will also inform the development of new funding initiatives to optimize the use of precision medicine in cancer treatment. Additionally, information collected as part of this survey will be used to develop physician educational materials to address barriers to precision medicine in cancer care delivery. OMB approval is requested for 2 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 350." />

81 FR 9869 - Submission for OMB Review; 30-Day Comment Request: The National Physician Survey of Precision Medicine in Cancer Treatment (NCI)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 38 (February 26, 2016)

Page Range9869-9870
FR Document2016-04105

Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Cancer Institute, the National Institutes of Health, has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on November 18, 2015 (80 FR 72077), and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Cancer Institute (NCI), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. For Further Information Contact: To obtain a copy of the data collection plans and instruments, or request more information on the proposed project, contact: Janet S. de Moor, Ph.D., MPH, Project Officer, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, 3E438, MSC 9764, Rockville, MD, 20850 or call non-toll-free number 240-276-6806 or Email your request, including your address to: [email protected] Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: The National Physician Survey of Precision Medicine in Cancer Treatment 0925-NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: The purpose of this study is to investigate the current practice of precision medicine in cancer treatment among medical oncologists in the U.S. This is a nationally representative survey designed to assess oncologists' current and potential use of genomic testing, to inform the development of interventions to facilitate optimal use of genomic testing and to improve patient-physician discussions of the risks, possible benefits, and uncertainties surrounding the use of these tests. Current knowledge of this topic is limited as there are no nationally-representative studies on this topic to date. There are only two non-federal studies two that have examined physicians' knowledge and attitudes regarding somatic genetic and genomic testing. The survey will be administered by mail and web to medical oncology physicians across the U.S. Non- respondents will be invited to complete a follow-back survey to share their reasons for not participating. The study findings will inform NCI of relevant issues and concerns relating to the application of precision medicine to current and future cancer treatment patterns and practice. This information will also inform the development of new funding initiatives to optimize the use of precision medicine in cancer treatment. Additionally, information collected as part of this survey will be used to develop physician educational materials to address barriers to precision medicine in cancer care delivery. OMB approval is requested for 2 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 350.

Federal Register, Volume 81 Issue 38 (Friday, February 26, 2016)
[Federal Register Volume 81, Number 38 (Friday, February 26, 2016)]
[Notices]
[Pages 9869-9870]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-04105]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request: The National 
Physician Survey of Precision Medicine in Cancer Treatment (NCI)

    Summary: Under the provisions of Section 3507(a)(1)(D) of the 
Paperwork Reduction Act of 1995, the National Cancer Institute, the 
National Institutes of Health, has submitted to the Office of 
Management and Budget (OMB) a request for review and approval of the 
information collection listed below. This proposed information 
collection was previously published in the Federal Register on November 
18, 2015 (80 FR 72077), and allowed 60-days for public comment. No 
public comments were received. The purpose of this notice is to allow 
an additional 30 days for public comment. The National Cancer Institute 
(NCI), National Institutes of Health, may not conduct or sponsor, and 
the respondent is not required to respond to, an information collection 
that has been extended, revised, or implemented on or after October 1, 
1995, unless it displays a currently valid OMB control number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, [email protected] or by fax to 202-395-6974, 
Attention: NIH Desk Officer.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30 days 
of the date of this publication.
    For Further Information Contact: To obtain a copy of the data 
collection plans and instruments, or request more information on the 
proposed project, contact: Janet S. de Moor, Ph.D., MPH, Project 
Officer, Division of Cancer Control and Population Sciences, 9609 
Medical Center Drive, 3E438, MSC 9764, Rockville, MD, 20850 or call 
non-toll-free number 240-276-6806 or Email your request, including your 
address to: [email protected]. Formal requests for additional plans 
and instruments must be requested in writing.
    Proposed Collection: The National Physician Survey of Precision 
Medicine in Cancer Treatment 0925-NEW, National Cancer Institute (NCI), 
National Institutes of Health (NIH).
    Need and Use of Information Collection: The purpose of this study 
is to investigate the current practice of precision medicine in cancer 
treatment among medical oncologists in the U.S. This is a nationally 
representative survey designed to assess oncologists' current and 
potential use of genomic testing, to inform the development of 
interventions to facilitate optimal use of genomic testing and to 
improve patient-physician discussions of the risks, possible benefits, 
and uncertainties surrounding the use of these tests. Current knowledge 
of this topic is limited as there are no nationally-representative 
studies on this topic to date. There are only two non-federal studies 
two that have examined physicians' knowledge and attitudes regarding 
somatic genetic and genomic testing. The survey will be administered by 
mail and web to medical oncology physicians across the U.S. Non-
respondents will be invited to complete a follow-back survey to share 
their reasons for not participating. The study findings will inform NCI 
of relevant issues and concerns relating to the application of 
precision medicine to current and future cancer treatment patterns and 
practice. This information will also inform the development of new 
funding initiatives to optimize the use of precision medicine in cancer 
treatment. Additionally, information collected as part of this survey 
will be used to develop physician educational materials to address 
barriers to precision medicine in cancer care delivery.
    OMB approval is requested for 2 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 350.

                                          Total Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                     Type of         Number of       Number of      burden per     Total annual
           Form name               respondent       respondents    responses per   response  (in    burden hour
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Telephone Screener............  Receptionists...             775               1            3/60              39
Precision Medicine Survey--     Oncology                     175               1           20/60              58
 Pilot Study.                    Physicians.
Precision Medicine Survey--     Oncology                     600               1           20/60             200
 Full Study.                     Physicians.
Non-response Follow-back        Oncology                      40               1            5/60               3
 Survey.                         Physicians.

[[Page 9870]]

 
Telephone Reminder Script.....  Receptionists...             600               1            5/60              50
                                                 ---------------------------------------------------------------
    Total.....................  ................           1,375           2,190  ..............             350
----------------------------------------------------------------------------------------------------------------


    Dated: February 11, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer Institute, NIH.
[FR Doc. 2016-04105 Filed 2-25-16; 8:45 am]
 BILLING CODE 4140-01-P



                                                                                    Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Notices                                                    9869

                                                  evidence that environmental chemicals,                        DEPARTMENT OF HEALTH AND                                 9764, Rockville, MD, 20850 or call non-
                                                  physical substances, or mixtures                              HUMAN SERVICES                                           toll-free number 240–276–6806 or Email
                                                  (collectively referred to as ‘‘substances’’)                                                                           your request, including your address to:
                                                  cause adverse health effects and                              National Institutes of Health                            janet.demoor@nih.gov. Formal requests
                                                  provides opinions on whether these                                                                                     for additional plans and instruments
                                                                                                                Submission for OMB Review; 30-Day                        must be requested in writing.
                                                  substances may be of concern given
                                                                                                                Comment Request: The National                               Proposed Collection: The National
                                                  what is known about current human
                                                                                                                Physician Survey of Precision                            Physician Survey of Precision Medicine
                                                  exposure levels. OHAT also organizes                          Medicine in Cancer Treatment (NCI)
                                                  workshops or state-of-the-science                                                                                      in Cancer Treatment 0925–NEW,
                                                  evaluations to address issues of                                Summary: Under the provisions of                       National Cancer Institute (NCI),
                                                  importance in environmental health                            Section 3507(a)(1)(D) of the Paperwork                   National Institutes of Health (NIH).
                                                  sciences. Information about OHAT is                           Reduction Act of 1995, the National                         Need and Use of Information
                                                  found at http://ntp.niehs.nih.gov/go/                         Cancer Institute, the National Institutes                Collection: The purpose of this study is
                                                                                                                of Health, has submitted to the Office of                to investigate the current practice of
                                                  ohat.
                                                                                                                Management and Budget (OMB) a                            precision medicine in cancer treatment
                                                     Background Information on NTP Peer                         request for review and approval of the                   among medical oncologists in the U.S.
                                                  Review Panels: NTP panels are                                 information collection listed below.                     This is a nationally representative
                                                  technical, scientific advisory bodies                         This proposed information collection                     survey designed to assess oncologists’
                                                  established on an ‘‘as needed’’ basis to                      was previously published in the Federal                  current and potential use of genomic
                                                  provide independent scientific peer                           Register on November 18, 2015 (80 FR                     testing, to inform the development of
                                                  review and advise the NTP on agents of                        72077), and allowed 60-days for public                   interventions to facilitate optimal use of
                                                  public health concern, new/revised                            comment. No public comments were                         genomic testing and to improve patient-
                                                  toxicological test methods, or other                          received. The purpose of this notice is                  physician discussions of the risks,
                                                  issues. These panels help ensure                              to allow an additional 30 days for public                possible benefits, and uncertainties
                                                  transparent, unbiased, and scientifically                     comment. The National Cancer Institute                   surrounding the use of these tests.
                                                  rigorous input to the program for its use                     (NCI), National Institutes of Health, may                Current knowledge of this topic is
                                                  in making credible decisions about                            not conduct or sponsor, and the                          limited as there are no nationally-
                                                  human hazard, setting research and                            respondent is not required to respond                    representative studies on this topic to
                                                  testing priorities, and providing                             to, an information collection that has                   date. There are only two non-federal
                                                  information to regulatory agencies about                      been extended, revised, or implemented                   studies two that have examined
                                                  alternative methods for toxicity                              on or after October 1, 1995, unless it                   physicians’ knowledge and attitudes
                                                                                                                displays a currently valid OMB control                   regarding somatic genetic and genomic
                                                  screening. The NTP welcomes
                                                                                                                number.                                                  testing. The survey will be administered
                                                  nominations of scientific experts for
                                                                                                                  Direct Comments to OMB: Written                        by mail and web to medical oncology
                                                  upcoming panels. Scientists interested
                                                                                                                comments and/or suggestions regarding                    physicians across the U.S. Non-
                                                  in serving on an NTP panel should                                                                                      respondents will be invited to complete
                                                                                                                the item(s) contained in this notice,
                                                  provide current curriculum vitae to the                                                                                a follow-back survey to share their
                                                                                                                especially regarding the estimated
                                                  FOR FURTHER INFORMATION CONTACT. The                                                                                   reasons for not participating. The study
                                                                                                                public burden and associated response
                                                  authority for NTP panels is provided by                                                                                findings will inform NCI of relevant
                                                                                                                time, should be directed to the: Office
                                                  42 U.S.C. 217a; section 222 of the Public                     of Management and Budget, Office of                      issues and concerns relating to the
                                                  Health Service (PHS) Act, as amended.                         Regulatory Affairs, OIRA_submission@                     application of precision medicine to
                                                  The panel is governed by the Federal                          omb.eop.gov or by fax to 202–395–6974,                   current and future cancer treatment
                                                  Advisory Committee Act, as amended (5                         Attention: NIH Desk Officer.                             patterns and practice. This information
                                                  U.S.C. Appendix 2), which sets forth                            Comment Due Date: Comments                             will also inform the development of
                                                  standards for the formation and use of                        regarding this information collection are                new funding initiatives to optimize the
                                                  advisory committees.                                          best assured of having their full effect if              use of precision medicine in cancer
                                                    Dated: February 22, 2016.                                   received within 30 days of the date of                   treatment. Additionally, information
                                                                                                                this publication.                                        collected as part of this survey will be
                                                  John R. Bucher,
                                                                                                                  For Further Information Contact: To                    used to develop physician educational
                                                  Associate Director, NTP.                                      obtain a copy of the data collection                     materials to address barriers to precision
                                                  [FR Doc. 2016–04102 Filed 2–25–16; 8:45 am]                   plans and instruments, or request more                   medicine in cancer care delivery.
                                                  BILLING CODE 4140–01–P                                        information on the proposed project,                        OMB approval is requested for 2
                                                                                                                contact: Janet S. de Moor, Ph.D., MPH,                   years. There are no costs to respondents
                                                                                                                Project Officer, Division of Cancer                      other than their time. The total
                                                                                                                Control and Population Sciences, 9609                    estimated annualized burden hours are
                                                                                                                Medical Center Drive, 3E438, MSC                         350.

                                                                                                                  TOTAL ANNUALIZED BURDEN HOURS
                                                                                                                                                                                             Average
                                                                                                                                                                         Number of
                                                                                                                           Type of                     Number of                           burden per     Total annual
                                                                       Form name                                                                                       responses per
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                                                                                         respondent                   respondents                           response      burden hour
                                                                                                                                                                         respondent         (in hours)

                                                  Telephone Screener .......................................   Receptionists ......................              775                 1             3/60             39
                                                  Precision Medicine Survey—Pilot Study ........               Oncology Physicians ..........                    175                 1            20/60             58
                                                  Precision Medicine Survey—Full Study ..........              Oncology Physicians ..........                    600                 1            20/60            200
                                                  Non-response Follow-back Survey .................            Oncology Physicians ..........                     40                 1             5/60              3




                                             VerDate Sep<11>2014     20:41 Feb 25, 2016    Jkt 238001    PO 00000     Frm 00066     Fmt 4703    Sfmt 4703   E:\FR\FM\26FEN1.SGM   26FEN1


                                                  9870                                   Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Notices

                                                                                                                  TOTAL ANNUALIZED BURDEN HOURS—Continued
                                                                                                                                                                                                                  Average
                                                                                                                                                                                           Number of
                                                                                                                                        Type of                           Number of                             burden per              Total annual
                                                                          Form name                                                                                                      responses per
                                                                                                                                      respondent                         respondents                             response               burden hour
                                                                                                                                                                                           respondent            (in hours)

                                                  Telephone Reminder Script ............................                 Receptionists ......................                      600                 1                     5/60                 50

                                                       Total .........................................................   .............................................           1,375              2,190    ........................            350



                                                    Dated: February 11, 2016.                                             FOR FURTHER INFORMATION CONTACT:                                 biographical information and is usually
                                                  Karla Bailey,                                                           Requests for additional information                              completed by licensed Cartmen or
                                                  Project Clearance Liaison, National Cancer                              should be directed to Tracey Denning,                            Lightermen whose duties require
                                                  Institute, NIH.                                                         U.S. Customs and Border Protection,                              receiving, transporting, or otherwise
                                                  [FR Doc. 2016–04105 Filed 2–25–16; 8:45 am]                             Regulations and Rulings, Office of                               handling imported merchandise which
                                                  BILLING CODE 4140–01–P                                                  International Trade, 90 K Street NE.,                            has not been released from CBP custody.
                                                                                                                          10th Floor, Washington, DC 20229–                                This form is submitted to the local CBP
                                                                                                                          1177, at 202–325–0265.                                           office at the port of entry that the
                                                  DEPARTMENT OF HOMELAND                                                  SUPPLEMENTARY INFORMATION: This                                  respondent will be requesting access to
                                                  SECURITY                                                                proposed information collection was                              the Federal Inspection Section. Form
                                                                                                                          previously published in the Federal                              3078 is authorized by 19 U.S.C. 66,
                                                  U.S. Customs and Border Protection                                      Register (80 FR 66915) on October 30,                            1551, 1555, 1565, 1624, 1641; and 19
                                                                                                                          2015, allowing for a 60-day comment                              CFR 112.42, 118, 122.182, and 146.6.
                                                  [1651–0008]
                                                                                                                          period. This notice allows for an                                This form is accessible at: http://www.
                                                  Agency Information Collection                                           additional 30 days for public comments.                          cbp.gov/sites/default/files/documents/
                                                  Activities: Application for Identification                              This process is conducted in accordance                          CBP%20Form%203078.pdf.
                                                  Card                                                                    with 5 CFR 1320.10. CBP invites the                                Action: CBP proposes to extend the
                                                                                                                          general public and other Federal                                 expiration date of this information
                                                  AGENCY:  U.S. Customs and Border                                        agencies to comment on proposed and/                             collection with no change to the
                                                  Protection, Department of Homeland                                      or continuing information collections                            estimated burden hours or to CBP Form
                                                  Security.                                                               pursuant to the Paperwork Reduction                              3078.
                                                  ACTION: 30-Day notice and request for                                   Act of 1995 (Pub. L. 104–13; 44 U.S.C.                             Type of Review: Extension (without
                                                  comments; Extension of an existing                                      3507). The comments should address:                              change).
                                                  collection of information.                                              (a) Whether the collection of                                      Affected Public: Businesses.
                                                                                                                          information is necessary for the proper                            Estimated Number of Respondents:
                                                  SUMMARY:    U.S. Customs and Border                                     performance of the functions of the                              150,000.
                                                  Protection (CBP) of the Department of                                   agency, including whether the                                      Estimated Number of Total Annual
                                                  Homeland Security will be submitting                                    information shall have practical utility;                        Responses: 150,000.
                                                  the following information collection                                    (b) the accuracy of the agency’s                                   Estimated Time per Response: 17
                                                  request to the Office of Management and                                 estimates of the burden of the collection                        minutes.
                                                  Budget (OMB) for review and approval                                    of information; (c) ways to enhance the                            Estimated Total Annual Burden
                                                  in accordance with the Paperwork                                        quality, utility, and clarity of the                             Hours: 42,450.
                                                  Reduction Act: Application for                                          information to be collected; (d) ways to                           Dated: February 22, 2016.
                                                  Identification Card (CBP Form 3078).                                    minimize the burden, including the use
                                                  This is a proposed extension of an                                                                                                       Tracey Denning,
                                                                                                                          of automated collection techniques or                            Agency Clearance Officer, U.S. Customs and
                                                  information collection that was                                         the use of other forms of information
                                                  previously approved. CBP is proposing                                                                                                    Border Protection.
                                                                                                                          technology; and (e) the annual costs to                          [FR Doc. 2016–04121 Filed 2–25–16; 8:45 am]
                                                  that this information collection be                                     respondents or record keepers from the
                                                  extended with no change to the burden                                   collection of information (total capital/
                                                                                                                                                                                           BILLING CODE 9111–14–P
                                                  hours or to the information collected.                                  startup costs and operations and
                                                  This document is published to obtain                                    maintenance costs). The comments that
                                                  comments from the public and affected                                                                                                    DEPARTMENT OF HOMELAND
                                                                                                                          are submitted will be summarized and                             SECURITY
                                                  agencies.                                                               included in the CBP request for OMB
                                                  DATES: Written comments should be                                       approval. All comments will become a                             U.S. Customs and Border Protection
                                                  received on or before March 28, 2016 to                                 matter of public record. In this
                                                  be assured of consideration.                                            document, CBP is soliciting comments                             [1651–0014]
                                                  ADDRESSES: Interested persons are                                       concerning the following information
                                                  invited to submit written comments on                                   collection:                                                      Agency Information Collection
                                                  this proposed information collection to                                    Title: Application for Identification                         Activities: Declaration for Free Entry of
                                                                                                                                                                                           Unaccompanied Articles
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                  the Office of Information and Regulatory                                Card.
                                                  Affairs, Office of Management and                                          OMB Number: 1651–0008.                                        AGENCY:  U.S. Customs and Border
                                                  Budget. Comments should be addressed                                       Form Number: CBP Form 3078.                                   Protection, Department of Homeland
                                                  to the OMB Desk Officer for Customs                                        Abstract: CBP Form 3078, Application                          Security.
                                                  and Border Protection, Department of                                    for Identification Card, is filled out in
                                                                                                                                                                                           ACTION: 60-Day notice and request for
                                                  Homeland Security, and sent via                                         order to obtain an Identification Card
                                                                                                                                                                                           comments; extension of an existing
                                                  electronic mail to oira_submission@                                     which is used to gain access to CBP
                                                                                                                                                                                           collection of information.
                                                  omb.eop.gov or faxed to (202) 395–5806.                                 security areas. This form collects


                                             VerDate Sep<11>2014       20:41 Feb 25, 2016         Jkt 238001      PO 00000        Frm 00067        Fmt 4703       Sfmt 4703   E:\FR\FM\26FEN1.SGM   26FEN1



Document Created: 2018-02-02 14:37:16
Document Modified: 2018-02-02 14:37:16
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesComments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication.
ContactTo obtain a copy of the data collection plans and instruments, or request more information on the proposed project, contact: Janet S. de Moor, Ph.D., MPH, Project Officer, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, 3E438, MSC 9764, Rockville, MD, 20850 or call non-toll-free number 240-276-6806 or Email your request, including your
FR Citation81 FR 9869 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR